Uniform Cell Aggregations via Hydrogel Encapsulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a demand for a cell population with uniform-sized and shaped cell aggregations, as uniformity is crucial for reliable test results in drug discovery research and for maintaining the differentiation potency of stem cells, but existing methods fail to consistently produce such uniformity.

Innovation Solution

A cell population is produced by encapsulating cells in a tubular hydrogel, where the hydrogel has a specific storage modulus and M/G ratio, and the cells are cultured to achieve a coefficient of variation in size and shape of 0.50 or less, ensuring uniform cell aggregations are formed.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If cells are cultured using conventional monolayer culture methods, then the culture process is simple and cells can be easily maintained, but the cell state does not reflect in-vivo conditions and specific functions are not properly developed

Engineering Contradiction:
Improvereliability of test resultsVSAvoidculture system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent changes the culture dimensionality parameter from 2D monolayer to 3D spheroid configuration, and modifies the physical environment by introducing hydrogel encapsulation. These parameter changes transform the culture system to better mimic in-vivo conditions, improving the reliability of drug discovery test results while maintaining manageable complexity through standardized hydrogel formulations

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces hydrogel as an intermediary substance that encapsulates cells and provides a controlled microenvironment. This intermediary enables the transition from simple monolayer culture to complex 3D spheroid culture by mediating cell-cell and cell-matrix interactions, allowing reliable in-vivo-like conditions without requiring complex external control systems

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If cell aggregations are produced without uniformity control, then the production process is simpler and faster, but the cell aggregations vary in size and shape making them difficult to handle and test

Engineering Contradiction:
Improveuniformity of cell aggregation size and shapeVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent controls the uniformity of cell aggregations by precisely controlling hydrogel concentration, crosslinking conditions, and cell seeding density. These parameter changes ensure that cell aggregations achieve consistent size and shape (coefficient of variation ≤0.50) while maintaining production efficiency through scalable hydrogel-based encapsulation processes

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent enables cell aggregations to self-organize into uniform spheroids within the hydrogel matrix through controlled self-assembly mechanisms. The hydrogel provides a confined environment that guides cell aggregation into uniform structures without requiring external manipulation, achieving manufacturing precision while maintaining productivity

Inventive Principle:
Principle #25Self-service

3Reliability

If stem cells are cultured in cell aggregations of varying sizes, then the culture process is simpler, but the differentiation potency changes unpredictably

Engineering Contradiction:
Improvedifferentiation potency consistencyVSAvoidculture control complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent controls the differentiation potency by precisely controlling the size parameter of cell aggregations through hydrogel encapsulation. By maintaining uniform aggregation size (coefficient of variation ≤0.50) and controlling the cell-to-hydrogel ratio, the system ensures consistent differentiation outcomes while managing culture control complexity through standardized hydrogel formulations and encapsulation protocols

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively produces cell populations with uniform cell aggregations, maintaining their differentiation potency and facilitating reliable drug discovery research by ensuring consistent test results.

Implementation Method 1

a hydrogel encapsulating the large number of cell aggregations

Methodology Applied
Scientific EffectGelation: Gel

Implementation Method 2

a storage modulus of the hydrogel in a state of encapsulating the large number of cell aggregations is 100 Pa or more

Methodology Applied
Scientific EffectElasticity: Elasticity

Data Source

PatentUS20240400981A1Cell population and cell population production method
Publication Date: 2024.12.05 CELLFIBER CO LTD
  • US20240400981A1 patent drawing
  • US20240400981A1 patent drawing
  • US20240400981A1 patent drawing

AI summary

A cell population comprises a large number of cell aggregations and a hydrogel encapsulating the large number of cell aggregations. A coefficient of variation obtained by dividing a standard deviation of sizes of the large number of cell aggregations by a mean value of the sizes of the large number of cell masses is 0.50 or less. Alternatively and/or in addition there to, a coefficient of variation obtained by dividing a standard deviation of aspect ratios of shapes of the large number of cell aggregations by a mean value of the aspect ratios of the shapes of the large number of cell aggregations is 0.30 or less.